Form D — Zyus Life Sciences Corp
0002036745-25-000005 · filed 2025-08-13
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $726,198
- Total sold
- $72,768
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Zyus Life Sciences Corp
- CIK
- 2036745
- Entity
- Corporation
- Jurisdiction
- ONTARIO, CANADA
- Year incorporated
- —
- Address
- 407 DOWNEY ROAD
SASKATOON, A9 S7N 4L8 - Phone
- (306) 242-2357
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Brett Zettl · Executive OfficerSaskatoon, A9 Find on LinkedIn ↗
-
John Hyshka · Executive OfficerSaskatoon, A9 Find on LinkedIn ↗
-
Keith Carpenter · Executive OfficerSaskatoon, A9 Find on LinkedIn ↗
-
Dr. Julie Stakiw · Executive OfficerSaskatoon, A9 Find on LinkedIn ↗
-
Richard Hoyt · DirectorSaskatoon, A9 Find on LinkedIn ↗
-
John Knowles · DirectorSaskatoon, A9 Find on LinkedIn ↗
-
Garnette Weber · DirectorSaskatoon, A9 Find on LinkedIn ↗
-
Wayne Brownlee · DirectorSaskatoon, A9 Find on LinkedIn ↗
-
Dr. Charlotte Moore Hepburn · DirectorSaskatoon, A9 Find on LinkedIn ↗
View original on SEC EDGAR.